{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:22:31Z","timestamp":1790752951814,"version":"4.1.0"},"reference-count":427,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["18-CE14-0008-01"],"award-info":[{"award-number":["18-CE14-0008-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM EQU201903007854"],"award-info":[{"award-number":["FRM EQU201903007854"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CARPEM"},{"DOI":"10.13039\/501100004097","name":"Fondation ARC","doi-asserted-by":"publisher","award":["ANR-18-CE14\u20130021"],"award-info":[{"award-number":["ANR-18-CE14\u20130021"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) usually present bilateral benign adrenocortical macronodules at imaging and variable levels of cortisol excess. PBMAH is a rare cause of primary overt Cushing's syndrome but may represent up to one-third of bilateral adrenal incidentalomas with evidence of cortisol excess. The increased steroidogenesis in PBMAH is often regulated by various G protein\u2013coupled receptors (GPCRs) aberrantly expressed in PBMAH tissues; some receptor ligands are ectopically produced in PBMAH tissues, creating aberrant autocrine\/paracrine regulation of steroidogenesis.<\/jats:p>\n                  <jats:p>The bilateral nature of PBMAH and familial aggregation led to the identification of germline heterozygous inactivating mutations of the ARMC5 gene, in 20% to 25% of the apparent sporadic cases and more frequently in familial cases; ARMC5 mutations\/pathogenic variants can be associated with meningiomas. More recently, combined germline mutations\/pathogenic variants and somatic events inactivating the KDM1A gene were specifically identified in patients affected by glucose-dependent insulinotropic peptide (GIP)-dependent PBMAH. Functional studies demonstrated that inactivation of KDM1A leads to GIP-receptor (GIPR) overexpression and over- or downregulation of other GPCRs. Genetic analysis is now available for early detection of family members of index cases with PBMAH carrying identified germline pathogenic variants. Detailed biochemical, imaging, and comorbidity assessment of the nature and severity of PBMAH is essential for its management. Treatment is reserved for patients with overt or mild cortisol\/aldosterone or other steroid excesses, taking in account comorbidities. It previously relied on bilateral adrenalectomy; however, recent studies tend to favor unilateral adrenalectomy or, less frequently, medical treatment with cortisol synthesis inhibitors or specific blockers of aberrant GPCR.<\/jats:p>","DOI":"10.1210\/endrev\/bnac034","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:35:45Z","timestamp":1671726945000},"page":"567-628","source":"Crossref","is-referenced-by-count":88,"title":["Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia"],"prefix":"10.1210","volume":"44","author":[{"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"first","affiliation":[{"name":"Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Cochin Hospital, Assistance Publique H\u00f4pitaux de Paris , 24 rue du Fg St Jacques, 75014 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8000-4313","authenticated-orcid":false,"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine and Research Center, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) , Montr\u00e9al, Qu\u00e9bec H2X 0A9 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Bouys","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Cochin Hospital, Assistance Publique H\u00f4pitaux de Paris , 24 rue du Fg St Jacques, 75014 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Chasseloup","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie et des Maladies de la Reproduction Universit\u00e9, Paris-Saclay, INSERM, Physiologie et Physiopathologie Endocriniennes , 94276 Le Kremlin-Bic\u00eatre , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie et des Maladies de la Reproduction Universit\u00e9, Paris-Saclay, INSERM, Physiologie et Physiopathologie Endocriniennes , 94276 Le Kremlin-Bic\u00eatre , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-3025","authenticated-orcid":false,"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine and Research Center, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) , Montr\u00e9al, Qu\u00e9bec H2X 0A9 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"issue":"10","key":"2023071114171614000_bnac034-B1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jcem-24-10-947","article-title":"Cushing's syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor","volume":"24","author":"Kirschner","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1310067","article-title":"ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's Syndrome with major diagnostic and therapeutic implications","volume":"131","author":"Lieberman","year":"1994","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023071114171614000_bnac034-B3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-2008-1058678","article-title":"[Bilateral massive macronodular adrenal gland hyperplasia. A rare cause of Cushing's syndrome]","volume":"119","author":"Strohm","year":"1994","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"2023071114171614000_bnac034-B4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00004728-199109000-00009","article-title":"CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism","volume":"15","author":"Doppman","year":"1991","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"2023071114171614000_bnac034-B5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1507\/endocrj1954.36.101","article-title":"\u201cGIANT\u201d macronodular adrenal hyperplasia causing Cushing's Syndrome: case report and review of the literature on a clinical distinction of adrenocortical nodular pathology associated with hypercortisolism","volume":"36","author":"Cugini","year":"1989","journal-title":"Endocrinol Jpn"},{"issue":"1","key":"2023071114171614000_bnac034-B6","first-page":"37","article-title":"[Cushing's syndrome due to huge bilateral adrenocortical multinodular hyperplasia\u2013ACTH-independent bilateral adrenocortical macronodular hyperplasia(AIMAH)]","volume":"70","author":"Aiba","year":"1994","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"issue":"2","key":"2023071114171614000_bnac034-B7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.beem.2008.10.011","article-title":"ACTH-independent macronodular adrenal hyperplasia","volume":"23","author":"Lacroix","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B8","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fendo.2015.00034","article-title":"Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism","volume":"6","author":"Lefebvre","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2023071114171614000_bnac034-B10","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 Mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B11","doi-asserted-by":"crossref","first-page":"bvac041","DOI":"10.1210\/jendso\/bvac041","article-title":"An overview of the heterogeneous causes of cushing syndrome resulting from primary macronodular adrenal hyperplasia (PMAH)","volume":"6","author":"Charchar","year":"2022","journal-title":"J Endocr Soc"},{"issue":"1","key":"2023071114171614000_bnac034-B12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"22","key":"2023071114171614000_bnac034-B13","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Engl J Med"},{"issue":"22","key":"2023071114171614000_bnac034-B14","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMe1312792","article-title":"Heredity and cortisol regulation in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Lacroix","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2023071114171614000_bnac034-B15","first-page":"75","article-title":"Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome","volume":"22","author":"Lacroix","year":"2001","journal-title":"Endocr Rev"},{"issue":"8","key":"2023071114171614000_bnac034-B16","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1530\/EC-19-0312","article-title":"Validity of discharge ICD-10 codes in detecting the etiologies of endogenous Cushing's syndrome","volume":"8","author":"Zhou","year":"2019","journal-title":"Endocr Connect"},{"issue":"9","key":"2023071114171614000_bnac034-B17","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023071114171614000_bnac034-B19","first-page":"281","article-title":"Cushing's syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"2","key":"2023071114171614000_bnac034-B20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cen.14014","article-title":"The incidence of endogenous Cushing's syndrome in the modern era","volume":"91","author":"Wengander","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023071114171614000_bnac034-B21","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B22","doi-asserted-by":"crossref","first-page":"101521","DOI":"10.1016\/j.beem.2021.101521","article-title":"Epidemiology and mortality of Cushing's syndrome","volume":"35","author":"Hakami","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B23","doi-asserted-by":"crossref","first-page":"e1362","DOI":"10.1210\/clinem\/dgaa752","article-title":"Epidemiology and comorbidity of adrenal cushing syndrome: A nationwide cohort study","volume":"106","author":"Ahn","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"9996","key":"2023071114171614000_bnac034-B24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"2023071114171614000_bnac034-B25","doi-asserted-by":"crossref","first-page":"7159696","DOI":"10.1155\/2019\/7159696","article-title":"Demographic characteristics, etiology, and comorbidities of patients with Cushing's syndrome: a 10-year retrospective study at a large general hospital in China","volume":"2019","author":"Zhou","year":"2019","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2023071114171614000_bnac034-B26","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2023071114171614000_bnac034-B27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"8","key":"2023071114171614000_bnac034-B28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7326\/M20-7946","article-title":"Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: a cohort study","volume":"174","author":"Kjellbom","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"2023071114171614000_bnac034-B29","doi-asserted-by":"crossref","first-page":"R567","DOI":"10.1530\/ERC-19-0240","article-title":"Diagnosis and management of primary bilateral macronodular adrenal hyperplasia","volume":"26","author":"Vassiliadi","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"2023071114171614000_bnac034-B30","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1210\/jc.2018-02204","article-title":"Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy","volume":"104","author":"Osswald","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023071114171614000_bnac034-B31","first-page":"5534","article-title":"Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome","volume":"86","author":"Bourdeau","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B32","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071114171614000_bnac034-B33","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/js.2019-00210","article-title":"ARMC5 alterations in primary macronodular adrenal hyperplasia (PMAH) and the clinical state of variant carriers","volume":"3","author":"Kyo","year":"2019","journal-title":"J Endocr Soc"},{"issue":"9","key":"2023071114171614000_bnac034-B34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/PAS.0b013e31821ec4ce","article-title":"Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome","volume":"35","author":"Carney","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2023071114171614000_bnac034-B35","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1210\/jc.2003-031225","article-title":"Activating gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome\u2013a European collaborative study","volume":"89","author":"Lumbroso","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"2023071114171614000_bnac034-B36","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"2023071114171614000_bnac034-B37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/jc.2002-021292","article-title":"Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone","volume":"88","author":"Goodarzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B38","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1210\/jc.2010-1222","article-title":"Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome","volume":"96","author":"Ghayee","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023071114171614000_bnac034-B39","first-page":"e6162","article-title":"A case of severe psychosis due to Cushing's syndrome secondary to primary bilateral macronodular adrenal hyperplasia","volume":"11","author":"Shah","year":"2019","journal-title":"Cureus"},{"issue":"2","key":"2023071114171614000_bnac034-B40","doi-asserted-by":"crossref","first-page":"101494","DOI":"10.1016\/j.beem.2021.101494","article-title":"Cardiovascular complications of mild autonomous cortisol secretion","volume":"35","author":"Aresta","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12893-017-0293-z","article-title":"A case of adrenocoricotrophic hormone -independent bilateral adrenocortical macronodular hyperplasia concomitant with primary aldosteronism","volume":"17","author":"Tokumoto","year":"2017","journal-title":"BMC Surg"},{"issue":"9","key":"2023071114171614000_bnac034-B42","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/DCR.0000000000001008","article-title":"Characteristics of adrenal masses in familial adenomatous polyposis","volume":"61","author":"Shiroky","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"2023071114171614000_bnac034-B44","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing's syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B46","first-page":"189","article-title":"Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia","volume":"76","author":"Findlay","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2265.1996.682504.x","article-title":"ACTH Independent Cushing's Syndrome occurring in siblings","volume":"44","author":"Minami","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2023071114171614000_bnac034-B48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1385\/ENDO:19:3:319","article-title":"Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland","volume":"19","author":"Miyamura","year":"2002","journal-title":"Endocrine"},{"issue":"6","key":"2023071114171614000_bnac034-B49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-2002-34590","article-title":"Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members","volume":"110","author":"Nies","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2023071114171614000_bnac034-B50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2005.02387.x","article-title":"Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia","volume":"63","author":"Lee","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023071114171614000_bnac034-B51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/eje.1.02324","article-title":"Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors","volume":"156","author":"Vezzosi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023071114171614000_bnac034-B52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2265.2008.03471.x","article-title":"Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds","volume":"70","author":"Gagliardi","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023071114171614000_bnac034-B53","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41574-022-00718-y","article-title":"Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease","volume":"18","author":"Cavalcante","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"22","key":"2023071114171614000_bnac034-B54","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 Mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"2023071114171614000_bnac034-B55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2023071114171614000_bnac034-B56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.gim.2021.09.018","article-title":"KDM1A Inactivation causes hereditary food-dependent Cushing's syndrome","volume":"24","author":"Vaczlavik","year":"2022","journal-title":"modify to Genet Med"},{"issue":"1","key":"2023071114171614000_bnac034-B57","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0039-6109(05)70412-6","article-title":"Surgical anatomy and embryology of the adrenal glands","volume":"80","author":"Avisse","year":"2000","journal-title":"Surg Clin North Am"},{"issue":"3","key":"2023071114171614000_bnac034-B58","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/cancers14030569","article-title":"Adrenal mass characterization in the era of quantitative imaging: state of the art","volume":"14","author":"Barat","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2023071114171614000_bnac034-B59","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.acra.2014.06.008","article-title":"Linear and volumetric evaluation of the adrenal gland\u2013MDCT-based measurements of the adrenals","volume":"21","author":"Schneller","year":"2014","journal-title":"Acad Radiol"},{"issue":"8","key":"2023071114171614000_bnac034-B60","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1007\/s00330-015-4063-y","article-title":"MDCT Linear and volumetric analysis of adrenal glands: normative data and multiparametric assessment","volume":"26","author":"Carsin-Vu","year":"2016","journal-title":"Eur Radiol"},{"issue":"10","key":"2023071114171614000_bnac034-B61","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s00330-010-1804-9","article-title":"Adrenal gland volume measurement in septic shock and control patients: a pilot study","volume":"20","author":"Nougaret","year":"2010","journal-title":"Eur Radiol"},{"key":"2023071114171614000_bnac034-B62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-21-1032","article-title":"Identification of predictive criteria for pathogenic variants of the primary bilateral macronodular adrenal hyperplasia gene ARMC5 in 352 unselected patients","volume":"187","author":"Bouys","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00261-020-02580-w","article-title":"CT And MR imaging of acute adrenal disorders","volume":"46","author":"Udare","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"2023071114171614000_bnac034-B64","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/EJE-18-0296","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas","volume":"179","author":"Bourdeau","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023071114171614000_bnac034-B65","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1102\/1470-7330.2013.0053","article-title":"Adrenal collision tumors and their mimics: multimodality imaging findings","volume":"13","author":"Katabathina","year":"2013","journal-title":"Cancer Imaging"},{"issue":"8","key":"2023071114171614000_bnac034-B66","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1210\/jc.2004-2572","article-title":"Collision\/composite tumors of the adrenal gland: a pitfall of scintigraphy imaging and hormone assays in the detection of adrenal metastasis","volume":"90","author":"Thorin-Savour\u00e9","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13304-011-0132-1","article-title":"Corticomedullary mixed tumor of the adrenal gland-a clinical and pathological chameleon: case report and review of literature","volume":"65","author":"Donatini","year":"2013","journal-title":"Updates Surg"},{"issue":"4","key":"2023071114171614000_bnac034-B68","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0022-5347(01)66895-2","article-title":"Combined adrenal myelolipoma and pheochromocytoma","volume":"154","author":"Ukimura","year":"1995","journal-title":"J Urol"},{"issue":"1","key":"2023071114171614000_bnac034-B69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1477-7819-12-45","article-title":"Imaging and management of a small cell lung cancer metastasis\/adrenal adenoma collision tumor: a case report and review of the literature","volume":"12","author":"Untch","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"4","key":"2023071114171614000_bnac034-B70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/20009666.2017.1362315","article-title":"An exceedingly rare adrenal collision tumor: adrenal adenoma-metastatic breast cancer-myelolipoma","volume":"7","author":"Liu","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"12","key":"2023071114171614000_bnac034-B71","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s00261-017-1200-x","article-title":"Collision and composite tumors; radiologic and pathologic correlation","volume":"42","author":"Sung","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"2023071114171614000_bnac034-B72","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3389\/fendo.2019.00618","article-title":"Coexistence of myelolipoma and primary bilateral macronodular adrenal hyperplasia with GIP-dependent Cushing's syndrome","volume":"10","author":"Larose","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2023071114171614000_bnac034-B73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s13256-021-02937-9","article-title":"Adrenocortical adenoma with myelolipomatous metaplasia: a potential diagnostic pitfall: a case report and review of the literature","volume":"15","author":"Anbardar","year":"2021","journal-title":"J Med Case Rep"},{"issue":"2","key":"2023071114171614000_bnac034-B74","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023071114171614000_bnac034-B75","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B76","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mayocpiqo.2017.11.002","article-title":"Clinical, biochemical, and radiological characteristics of a single-center retrospective cohort of 705 large adrenal tumors","volume":"2","author":"I\u00f1iguez-Ariza","year":"2018","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"3","key":"2023071114171614000_bnac034-B77","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiology.216.3.r00au40797","article-title":"Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism","volume":"216","author":"Doppman","year":"2000","journal-title":"Radiology"},{"issue":"4","key":"2023071114171614000_bnac034-B78","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2214\/ajr.172.4.10587135","article-title":"CT Appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome","volume":"172","author":"Sohaib","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2023071114171614000_bnac034-B79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2214\/ajr.171.1.9648789","article-title":"Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature","volume":"171","author":"Boland","year":"1998","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2023071114171614000_bnac034-B80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiology.179.2.2014283","article-title":"Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis","volume":"179","author":"Lee","year":"1991","journal-title":"Radiology"},{"issue":"3","key":"2023071114171614000_bnac034-B81","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s12020-021-02645-w","article-title":"Update on primary bilateral macronodular adrenal hyperplasia (PBMAH)","volume":"71","author":"Bouys","year":"2021","journal-title":"Endocrine"},{"issue":"12","key":"2023071114171614000_bnac034-B82","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1507\/endocrj.EJ20-0163","article-title":"Primary macronodular adrenal hyperplasia (PMAH) can be generated by a new ARMC5 germline variant (c.52C&gt;T (p.Gln18X))","volume":"67","author":"Zhang","year":"2020","journal-title":"Endocr J"},{"key":"2023071114171614000_bnac034-B83","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fendo.2020.00036","article-title":"Allelic variants of ARMC5 in patients with adrenal incidentalomas and in patients with Cushing's syndrome associated with bilateral adrenal nodules","volume":"11","author":"Mariani","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023071114171614000_bnac034-B84","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clinbiochem.2018.06.013","article-title":"Two cases of Cushing's syndrome due to primary bilateral macronodular adrenal hyperplasia secondary to aberrant adrenal expression of hormone receptors","volume":"59","author":"Juli\u00e1-Sanchis","year":"2018","journal-title":"Clin Biochem"},{"key":"2023071114171614000_bnac034-B85","article-title":"A case of renovascular hypertension with incidental primary bilateral macronodular adrenocortical hyperplasia","author":"Higashitani","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"18","key":"2023071114171614000_bnac034-B86","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.21037\/atm-20-5963","article-title":"Analysis of clinical and pathological features of primary bilateral macronodular adrenocortical hyperplasia compared with unilateral cortisol-secreting adrenal adenoma","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"issue":"2","key":"2023071114171614000_bnac034-B87","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0043-122074","article-title":"Successful treatment of estrogen excess in primary bilateral macronodular adrenocortical hyperplasia with leuprolide acetate","volume":"50","author":"Hannah-Shmouni","year":"2018","journal-title":"Horm Metab Res"},{"issue":"1","key":"2023071114171614000_bnac034-B88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-0642","article-title":"ARMC5 Mutations in a large French-Canadian family with cortisol-secreting \u03b2-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia","volume":"174","author":"Bourdeau","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023071114171614000_bnac034-B89","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1148\/rg.2020190080","article-title":"Technical and interpretive pitfalls in adrenal imaging","volume":"40","author":"Nandra","year":"2020","journal-title":"Radiographics"},{"issue":"1","key":"2023071114171614000_bnac034-B90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2214\/ajr.165.1.7785642","article-title":"Characterization of adrenal masses (&lt;5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures","volume":"165","author":"Mayo-Smith","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2023071114171614000_bnac034-B91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00330-018-5626-5","article-title":"Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis","volume":"29","author":"Platzek","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"2023071114171614000_bnac034-B92","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiol.2313030676","article-title":"Chemical shift MR imaging of hyperattenuating (&gt;10 HU) adrenal masses: does it still have a role?","volume":"231","author":"Haider","year":"2004","journal-title":"Radiology"},{"issue":"5","key":"2023071114171614000_bnac034-B93","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2214\/AJR.13.11389","article-title":"Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT","volume":"202","author":"Seo","year":"2014","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"2023071114171614000_bnac034-B94","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00261-017-1429-4","article-title":"The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results","volume":"43","author":"Romeo","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"2023071114171614000_bnac034-B95","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cen.13258","article-title":"Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism","volume":"86","author":"Degenhart","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2023071114171614000_bnac034-B96","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s40618-021-01540-5","article-title":"Volumetric evaluation of CT images of adrenal glands in primary aldosteronism","volume":"44","author":"Velema","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2023071114171614000_bnac034-B97","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0042-103686","article-title":"Use of 3-dimensional volumetric modeling of adrenal gland size in patients with primary pigmented nodular adrenocortical disease","volume":"48","author":"Chrysostomou","year":"2016","journal-title":"Horm Metab Res"},{"issue":"1","key":"2023071114171614000_bnac034-B98","doi-asserted-by":"crossref","first-page":"bvaa162","DOI":"10.1210\/jendso\/bvaa162","article-title":"Volumetric modeling of adrenal gland size in primary bilateral macronodular adrenocortical hyperplasia","volume":"5","author":"Wurth","year":"2021","journal-title":"J Endocr Soc"},{"issue":"11","key":"2023071114171614000_bnac034-B99","first-page":"1038","article-title":"A new and superior adrenal scanning agent, NP-59","volume":"16","author":"Sarkar","year":"1975","journal-title":"J Nucl Med"},{"issue":"2","key":"2023071114171614000_bnac034-B100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem-45-2-353","article-title":"A new and superior adrenal imaging agent, 131I-6\u00df-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans","volume":"45","author":"Sarkar","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/eje.0.1470013","article-title":"Functional scintigraphy of the adrenal gland","volume":"147","author":"Rubello","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023071114171614000_bnac034-B102","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.semnuclmed.2006.03.004","article-title":"Adrenal gland scintigraphy","volume":"36","author":"Avram","year":"2006","journal-title":"Semin Nucl Med"},{"issue":"1","key":"2023071114171614000_bnac034-B103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00006231-198501000-00005","article-title":"Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma","volume":"6","author":"Lindberg","year":"1985","journal-title":"Nucl Med Commun"},{"issue":"2","key":"2023071114171614000_bnac034-B104","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/EJE-08-0299","article-title":"Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study","volume":"160","author":"Fagour","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023071114171614000_bnac034-B105","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s00268-014-2482-6","article-title":"The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's Syndrome and the prediction of post-surgical hypoadrenalism","volume":"38","author":"Ricciato","year":"2014","journal-title":"World J Surg"},{"issue":"12","key":"2023071114171614000_bnac034-B106","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1507\/endocrj.EJ16-0281","article-title":"Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas","volume":"63","author":"Katabami","year":"2016","journal-title":"Endocr J"},{"issue":"1","key":"2023071114171614000_bnac034-B107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.11100569","article-title":"Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance","volume":"259","author":"Boland","year":"2011","journal-title":"Radiology"},{"issue":"1086","key":"2023071114171614000_bnac034-B108","doi-asserted-by":"crossref","first-page":"20170520","DOI":"10.1259\/bjr.20170520","article-title":"Diagnostic accuracy of 18F-FDG PET or PET\/CT for the characterization of adrenal masses: a systematic review and meta-analysis","volume":"91","author":"Kim","year":"2018","journal-title":"Br J Radiol"},{"issue":"5","key":"2023071114171614000_bnac034-B109","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1210\/jc.2008-2302","article-title":"18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients","volume":"94","author":"Groussin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B110","doi-asserted-by":"crossref","first-page":"213875","DOI":"10.1155\/2015\/213875","article-title":"Value of 18-F-FDG PET\/CT and CT in the diagnosis of indeterminate adrenal masses","volume":"2015","author":"Launay","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"11","key":"2023071114171614000_bnac034-B111","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1210\/jc.2011-1397","article-title":"18F-FDG-PET\/CT Imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased 18F-FDG uptake","volume":"96","author":"Alencar","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023071114171614000_bnac034-B112","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00003072-200207000-00010","article-title":"Adrenal hyperplasia in Cushing's syndrome demonstrated by FDG positron emission tomographic imaging","volume":"27","author":"Lin","year":"2002","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2023071114171614000_bnac034-B113","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00268-015-3242-y","article-title":"FDG PET\/CT scan and functional adrenal tumors: a pilot study for lateralization","volume":"40","author":"Patel","year":"2016","journal-title":"World J Surg"},{"issue":"3","key":"2023071114171614000_bnac034-B114","first-page":"20200034","article-title":"18F-Fluorodeoxyglucose positron emission tomography\/computed tomography findings in a patient with bilateral macronodular adrenal hyperplasia","volume":"6","author":"Pan","year":"2020","journal-title":"BJR Case Rep"},{"issue":"5","key":"2023071114171614000_bnac034-B115","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1148\/rg.2017170056","article-title":"CT Texture analysis: definitions, applications, biologic correlates, and challenges","volume":"37","author":"Lubner","year":"2017","journal-title":"Radiographics"},{"issue":"19","key":"2023071114171614000_bnac034-B116","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.7150\/jca.26356","article-title":"Adrenal incidentaloma: machine learning-based quantitative texture analysis of unenhanced CT can effectively differentiate sPHEO from lipid-poor adrenal adenoma","volume":"9","author":"Yi","year":"2018","journal-title":"J Cancer"},{"issue":"1","key":"2023071114171614000_bnac034-B117","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jmri.25954","article-title":"Characterization of adrenal lesions on unenhanced MRI using texture analysis: a machine-learning approach","volume":"48","author":"Romeo","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"2023071114171614000_bnac034-B118","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2214\/AJR.18.20097","article-title":"Can texture analysis be used to distinguish benign from malignant adrenal nodules on unenhanced CT, contrast-enhanced CT, or in-phase and opposed-phase MRI?","volume":"212","author":"Ho","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"2023071114171614000_bnac034-B119","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.rct.0000250105.93423.a2","article-title":"Computed tomographic histogram analysis in the diagnosis of lipid-poor adenomas: comparison to adrenal washout computed tomography","volume":"31","author":"Jhaveri","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"2023071114171614000_bnac034-B120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mri.2021.03.009","article-title":"Handcrafted MRI radiomics and machine learning: classification of indeterminate solid adrenal lesions","volume":"79","author":"Stanzione","year":"2021","journal-title":"Magn Reson Imaging"},{"issue":"4","key":"2023071114171614000_bnac034-B121","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jmri.25452","article-title":"ADC histogram analysis for adrenal tumor histogram analysis of apparent diffusion coefficient in differentiating adrenal adenoma from pheochromocytoma","volume":"45","author":"Umanodan","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"2023071114171614000_bnac034-B122","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/ijms23020637","article-title":"Diagnostic accuracy of CT texture analysis in adrenal masses: A systematic review","volume":"23","author":"Crimi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2023071114171614000_bnac034-B123","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023071114171614000_bnac034-B124","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/jc.2007-0596","article-title":"Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series","volume":"92","author":"Pecori Giraldi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B125","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1210\/jc.2008-0139","article-title":"Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses","volume":"93","author":"Elamin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B126","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1373\/clinchem.2003.029934","article-title":"Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"issue":"3","key":"2023071114171614000_bnac034-B127","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s12020-016-0956-z","article-title":"A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype","volume":"55","author":"Albiger","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"2023071114171614000_bnac034-B128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-07-0424","article-title":"Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome","volume":"157","author":"Kidambi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023071114171614000_bnac034-B129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/jcem-32-2-266","article-title":"Characterization of the normal temporal pattern of plasma corticosteroid levels","volume":"32","author":"Krieger","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s11102-022-01214-2","article-title":"Late night salivary cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing's syndrome)","volume":"25","author":"Raff","year":"2022","journal-title":"Pituitary"},{"issue":"1 Steroid Forma","key":"2023071114171614000_bnac034-B131","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1749-6632.1990.tb34300.x","article-title":"Steroid analysis in saliva for the assessment of endocrine function","volume":"595","author":"Read","year":"1990","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2023071114171614000_bnac034-B132","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1258\/000456307780480954","article-title":"Salivary cortisol reflects serum cortisol: analysis of circadian profiles","volume":"44","author":"Dorn","year":"2007","journal-title":"Ann Clin Biochem"},{"issue":"1-2","key":"2023071114171614000_bnac034-B133","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2007.03.009","article-title":"Saliva collection method affects predictability of serum cortisol","volume":"382","author":"Poll","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"10","key":"2023071114171614000_bnac034-B134","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1210\/jc.2004-2264","article-title":"Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test","volume":"90","author":"Viardot","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B135","first-page":"878","article-title":"Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests","volume":"84","author":"Castro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071114171614000_bnac034-B136","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1210\/jc.2002-020534","article-title":"Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome","volume":"87","author":"Papanicolaou","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023071114171614000_bnac034-B137","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1210\/jc.2003-030312","article-title":"Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome","volume":"88","author":"Putignano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023071114171614000_bnac034-B138","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1210\/jc.2003-031790","article-title":"Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes","volume":"89","author":"Yaneva","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B139","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2005-837667","article-title":"Salivary cortisol measurement\u2013a reliable method for the diagnosis of Cushing's syndrome","volume":"113","author":"Trilck","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"2023071114171614000_bnac034-B140","first-page":"1163","article-title":"A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-cushing states","volume":"83","author":"Papanicolaou","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B141","first-page":"357","article-title":"Midnight serum cortisol: comparison of healthy volunteers and hospitalized patients with Cushing's syndrome","volume":"62","author":"Pikkarainen","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"issue":"7","key":"2023071114171614000_bnac034-B142","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/ERC-20-0102","article-title":"Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia","volume":"27","author":"Hannah-Shmouni","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2023071114171614000_bnac034-B143","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B144","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/EJE-10-0962","article-title":"Assessment of ACTH assay variability: a multicenter study","volume":"164","author":"Pecori Giraldi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023071114171614000_bnac034-B145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/000456329703400302","article-title":"Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome\u2013recommendations for a protocol for biochemistry laboratories","volume":"34","author":"Wood","year":"1997","journal-title":"Ann Clin Biochem"},{"issue":"06","key":"2023071114171614000_bnac034-B146","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0029-1210910","article-title":"The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test","volume":"94","author":"Nickelsen","year":"1989","journal-title":"Exp Clin Endocrinol"},{"issue":"2","key":"2023071114171614000_bnac034-B147","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jalm\/jfaa193","article-title":"Yield of Serum dexamethasone measurement for reducing false-positive results of low-dose dexamethasone suppression testing","volume":"6","author":"Roper","year":"2021","journal-title":"J Appl Lab Med"},{"issue":"1","key":"2023071114171614000_bnac034-B148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03689.x","article-title":"Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction","volume":"73","author":"Lacroix","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2023071114171614000_bnac034-B149","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12020-011-9490-1","article-title":"Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas","volume":"40","author":"Vassiliadi","year":"2011","journal-title":"Endocrine"},{"issue":"3","key":"2023071114171614000_bnac034-B150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.2004.02048.x","article-title":"Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study","volume":"61","author":"Reznik","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10274","key":"2023071114171614000_bnac034-B151","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"2023071114171614000_bnac034-B152","doi-asserted-by":"crossref","first-page":"101486","DOI":"10.1016\/j.beem.2021.101486","article-title":"Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing's syndrome","volume":"35","author":"Meloche-Dumas","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B153","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EJE-10-0195","article-title":"Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome","volume":"163","author":"Lib\u00e9","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B154","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.2005.02411.x","article-title":"Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome","volume":"64","author":"SR","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023071114171614000_bnac034-B155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1081\/ERC-200043735","article-title":"Clinical and molecular genetic studies of bilateral adrenal hyperplasias","volume":"30","author":"Bourdeau","year":"2004","journal-title":"Endocr Res"},{"issue":"4","key":"2023071114171614000_bnac034-B156","first-page":"390","article-title":"ARMC5 Mutations are associated with high levels of proliferating cell nuclear antigen and the presence of the serotonin receptor 5HT4R in PMAH nodules","volume":"64","author":"Concei\u00e7\u00e3o","year":"2020","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B157","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cen.14445","article-title":"Steroidogenesis in patients with adrenal incidentalomas: extended steroid profile measured by liquid chromatography-mass spectrometry after ACTH stimulation and dexamethasone suppression","volume":"95","author":"Huayllas","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2023071114171614000_bnac034-B158","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2169\/internalmedicine.36.628","article-title":"Preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids","volume":"36","author":"Yamada","year":"1997","journal-title":"Intern Med"},{"issue":"4","key":"2023071114171614000_bnac034-B159","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1507\/endocrj.45.485","article-title":"A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids","volume":"45","author":"Hayashi","year":"1998","journal-title":"Endocr J"},{"issue":"6","key":"2023071114171614000_bnac034-B160","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B161","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2265.2000.01022.x","article-title":"Concurrent secretion of aldosterone and cortisol from an adrenal adenoma\u2014value of MRI in diagnosis","volume":"53","author":"Allan","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023071114171614000_bnac034-B162","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1291\/hypres.24.723","article-title":"Combined primary aldosteronism and preclinical Cushing's syndrome: an unusual case presentation of adrenal adenoma","volume":"24","author":"Honda","year":"2001","journal-title":"Hypertens Res"},{"issue":"8","key":"2023071114171614000_bnac034-B163","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2169\/internalmedicine.42.714","article-title":"A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone","volume":"42","author":"Adachi","year":"2003","journal-title":"Intern Med"},{"issue":"11","key":"2023071114171614000_bnac034-B164","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1253\/circj.69.1425","article-title":"Primary aldosteronism combined with preclinical Cushing's syndrome in an elderly patient","volume":"69","author":"Fujii","year":"2005","journal-title":"Circ J"},{"issue":"4","key":"2023071114171614000_bnac034-B165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism","volume":"164","author":"Sp\u00e4th","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023071114171614000_bnac034-B166","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/hr.2010.18","article-title":"Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism","volume":"33","author":"Willenberg","year":"2010","journal-title":"Hypertens Res"},{"issue":"5","key":"2023071114171614000_bnac034-B167","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B168","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ando.2016.02.003","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 2: first diagnostic steps","volume":"77","author":"Douillard","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"12","key":"2023071114171614000_bnac034-B169","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1210\/jc.2015-2662","article-title":"Unilateral adrenalectomy as a first-line treatment of Cushing's syndrome in patients with primary bilateral macronodular adrenal hyperplasia","volume":"100","author":"Debillon","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023071114171614000_bnac034-B170","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B171","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1530\/EJE-07-0253","article-title":"Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results","volume":"157","author":"Albiger","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B172","first-page":"57","article-title":"Functional implications of LH\/hCG receptors in pregnancy-induced cushing syndrome","volume":"1","author":"Pl\u00f6ckinger","year":"2017","journal-title":"J Endocr Soc"},{"issue":"4","key":"2023071114171614000_bnac034-B173","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1210\/jcem-68-4-855","article-title":"Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's Syndrome","volume":"68","author":"Malchoff","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B174","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2265.2007.02810.x","article-title":"Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens","volume":"66","author":"Kamenicky","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023071114171614000_bnac034-B175","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/a-1783-7901","article-title":"The importance of DHEA-S levels in Cushing's syndrome; is there a cut-off value in the differential diagnosis?","volume":"54","author":"Ciftci","year":"2022","journal-title":"Horm Metab Res"},{"issue":"12","key":"2023071114171614000_bnac034-B176","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1373\/clinchem.2017.271106","article-title":"Accurate-Mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders","volume":"63","author":"Hines","year":"2017","journal-title":"Clin Chem"},{"issue":"3","key":"2023071114171614000_bnac034-B177","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1373\/clinchem.2017.282582","article-title":"Plasma steroid metabolome profiling for diagnosis and subtyping patients with Cushing's syndrome","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"issue":"6","key":"2023071114171614000_bnac034-B178","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/er.2018-00262","article-title":"Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism","volume":"40","author":"Storbeck","year":"2019","journal-title":"Endocr Rev"},{"issue":"12","key":"2023071114171614000_bnac034-B179","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B180","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2017-01525","article-title":"Adrenocorticotropin acutely regulates pregnenolone sulfate production by the human adrenal in vivo and in vitro","volume":"103","author":"Rege","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B181","first-page":"786","article-title":"Low DHEAS: A sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas","volume":"102","author":"Dennedy","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B182","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12020-014-0387-7","article-title":"DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous?","volume":"48","author":"Yener","year":"2015","journal-title":"Endocrine"},{"issue":"4","key":"2023071114171614000_bnac034-B183","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-17-1071","article-title":"Significant prevalence of NR3C1 mutations in incidentally discovered bilateral adrenal hyperplasia: results of the French MUTA-GR study","volume":"178","author":"Vitellius","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023071114171614000_bnac034-B184","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI106608","article-title":"Abnormal hormone responses of an adrenocortical cancer adenyl cyclase","volume":"50","author":"Schorr","year":"1971","journal-title":"J Clin Invest"},{"issue":"18","key":"2023071114171614000_bnac034-B185","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1016\/S0021-9258(18)61876-9","article-title":"Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma","volume":"246","author":"Schorr","year":"1971","journal-title":"J Biol Chem"},{"issue":"6","key":"2023071114171614000_bnac034-B186","first-page":"530","article-title":"Cushing's syndrome with food-dependent periodic hormonogenesis","volume":"10","author":"Hamet","year":"1987","journal-title":"Clin Invest Med"},{"issue":"14","key":"2023071114171614000_bnac034-B187","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion\u2013a new cause of Cushing's syndrome","volume":"327","author":"Lacroix","year":"1992","journal-title":"N Engl J Med"},{"issue":"14","key":"2023071114171614000_bnac034-B188","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide","volume":"327","author":"Reznik","year":"1992","journal-title":"N Engl J Med"},{"issue":"9","key":"2023071114171614000_bnac034-B189","first-page":"3168","article-title":"Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells","volume":"81","author":"de Herder","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023071114171614000_bnac034-B190","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/jc.83.8.2781","article-title":"Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome","volume":"83","author":"N'Diaye","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3-4","key":"2023071114171614000_bnac034-B191","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3109\/07435809809032696","article-title":"Gastric inhibitory polypeptide (GIP) stimulates cortisol secretion, cAMP production and DNA synthesis in an adrenal adenoma responsible for food-dependent Cushing's syndrome","volume":"24","author":"Chabre","year":"1998","journal-title":"Endocr Res"},{"issue":"18","key":"2023071114171614000_bnac034-B192","doi-asserted-by":"crossref","first-page":"e92184","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"2023071114171614000_bnac034-B193","doi-asserted-by":"crossref","first-page":"M45","DOI":"10.1530\/EJE-15-0200","article-title":"Multiple aberrant hormone receptors in Cushing's syndrome","volume":"173","author":"El Ghorayeb","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2023071114171614000_bnac034-B194","first-page":"3531","article-title":"Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?","volume":"85","author":"Mircescu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B195","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1750-1172-8-142","article-title":"ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11\u03b2-hydroxylase","volume":"8","author":"Hofland","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2023071114171614000_bnac034-B196","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0030-1270523","article-title":"Transient efficacy of octreotide and pasireotide (SOM230) treatment in GIP-dependent Cushing's syndrome","volume":"43","author":"Preumont","year":"2011","journal-title":"Horm Metab Res"},{"issue":"3","key":"2023071114171614000_bnac034-B197","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/jc.2004-1256","article-title":"In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin\/gastric inhibitory polypeptide-dependent hypercortisolism","volume":"90","author":"Bertherat","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023071114171614000_bnac034-B198","first-page":"4514","article-title":"Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients","volume":"83","author":"Lebrethon","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071114171614000_bnac034-B199","first-page":"3817","article-title":"Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion","volume":"84","author":"Pralong","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023071114171614000_bnac034-B200","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/jc.84.8.2616","article-title":"Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome","volume":"84","author":"N'Diaye","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B201","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2265.2000.00932.x","article-title":"GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH","volume":"52","author":"Croughs","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"51\/52","key":"2023071114171614000_bnac034-B202","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1055\/s-2000-9524","article-title":"[Food-dependent Cushing's syndrome of long standing with mild clinical features]","volume":"125","author":"Gerl","year":"2000","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"2023071114171614000_bnac034-B203","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1210\/jcem.87.5.8458","article-title":"The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors","volume":"87","author":"Groussin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B204","first-page":"187","article-title":"Food-dependent Cushing's syndrome","volume":"67","author":"Messidoro","year":"2009","journal-title":"Neth J Med"},{"issue":"3","key":"2023071114171614000_bnac034-B205","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.4158\/EP12346.CR","article-title":"Adrenocorticotropic hormone independent macronodular adrenal hyperplasia due to aberrant receptor expression: is medical treatment always an option?","volume":"19","author":"Karapanou","year":"2013","journal-title":"Endocr Pract"},{"issue":"2","key":"2023071114171614000_bnac034-B206","first-page":"583","article-title":"Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies","volume":"86","author":"Tsagarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B207","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1590\/S0004-27302009000300005","article-title":"Analysis of glucose-dependent insulinotropic peptide receptor (GIPR) and luteinizing hormone receptor (LHCGR) expression in human adrenocortical hyperplasia","volume":"53","author":"Costa","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"8","key":"2023071114171614000_bnac034-B208","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/sj.onc.1207277","article-title":"Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators","volume":"23","author":"Bourdeau","year":"2004","journal-title":"Oncogene"},{"issue":"11","key":"2023071114171614000_bnac034-B209","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1210\/jc.2006-0538","article-title":"Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"91","author":"Louiset","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B210","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/cen.12763","article-title":"An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience","volume":"82","author":"Albiger","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023071114171614000_bnac034-B211","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1210\/en.2005-0921","article-title":"Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model","volume":"147","author":"Mazzuco","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"2023071114171614000_bnac034-B212","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1081\/ERC-200044046","article-title":"The Sp transcription factor family is involved in the cellular expression of the human GIP-R gene promoter","volume":"30","author":"Baldacchino","year":"2004","journal-title":"Endocr Res"},{"issue":"9","key":"2023071114171614000_bnac034-B213","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1210\/jc.2006-0221","article-title":"Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome","volume":"91","author":"Lampron","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"S1","key":"2023071114171614000_bnac034-B214","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jdi.12445","article-title":"Alternative form of glucose-dependent insulinotropic polypepide and its physiology","volume":"7","author":"Fujita","year":"2016","journal-title":"J Diabetes Investig"},{"issue":"4","key":"2023071114171614000_bnac034-B215","doi-asserted-by":"crossref","first-page":"M121","DOI":"10.1530\/EJE-15-0532","article-title":"Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?","volume":"173","author":"Drougat","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"20","key":"2023071114171614000_bnac034-B216","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM199711133372004","article-title":"Propranolol therapy for ectopic \u03b2-adrenergic receptors in adrenal Cushing's syndrome","volume":"337","author":"Lacroix","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"2023071114171614000_bnac034-B217","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2265.1998.00490.x","article-title":"In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia","volume":"49","author":"Daidoh","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023071114171614000_bnac034-B218","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","author":"St-Jean","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B219","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1507\/endocrj1954.36.655","article-title":"Cushing's syndrome due to huge nodular adrenocortical hyperplasia with fluctuation of urinary 17-OHCS excretion","volume":"36","author":"Makino","year":"1989","journal-title":"Endocrinol Jpn"},{"issue":"8","key":"2023071114171614000_bnac034-B220","first-page":"2336","article-title":"Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"80","author":"Horiba","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023071114171614000_bnac034-B221","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2169\/internalmedicine.36.536","article-title":"Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas\/carcinomas which showed a point mutation in the APC gene","volume":"36","author":"Yamakita","year":"1997","journal-title":"Intern Med"},{"issue":"8","key":"2023071114171614000_bnac034-B222","first-page":"2414","article-title":"Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension","volume":"82","author":"Lacroix","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023071114171614000_bnac034-B223","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/jc.2002-020067","article-title":"Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"87","author":"Mune","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B224","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2265.1997.3011151.x","article-title":"Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide","volume":"47","author":"Iida","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2023071114171614000_bnac034-B225","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2265.2007.03106.x","article-title":"Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?","volume":"68","author":"Joubert","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023071114171614000_bnac034-B226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-10-0058","article-title":"Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"163","author":"de Groot","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2023071114171614000_bnac034-B227","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2169\/internalmedicine.52.8869","article-title":"A marked difference in the vasopressin responsiveness between the adrenal glands in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"52","author":"Miyata","year":"2013","journal-title":"Intern Med"},{"issue":"1","key":"2023071114171614000_bnac034-B228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0413","article-title":"Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates","volume":"196","author":"Louiset","year":"2008","journal-title":"J Endocrinol"},{"issue":"10","key":"2023071114171614000_bnac034-B229","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.peptides.2008.06.011","article-title":"Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s)","volume":"29","author":"Suzuki","year":"2008","journal-title":"Peptides"},{"issue":"2","key":"2023071114171614000_bnac034-B230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-2265.2003.01963.x","article-title":"Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia","volume":"60","author":"Tatsuno","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2023071114171614000_bnac034-B231","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 Mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071114171614000_bnac034-B232","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.4158\/EP15756.OR","article-title":"GERMLINE DELETION OF ARMC5 IN FAMILIAL PRIMARY MACRONODULAR ADRENAL HYPERPLASIA","volume":"21","author":"Suzuki","year":"2015","journal-title":"Endocr Pract"},{"issue":"12","key":"2023071114171614000_bnac034-B233","first-page":"747","article-title":"[Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy]","volume":"97","author":"Im\u00f6hl","year":"2002","journal-title":"Med Klin (Munich)"},{"issue":"9","key":"2023071114171614000_bnac034-B234","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1590\/S0004-27302007000900007","article-title":"Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome","volume":"51","author":"Mazzuco","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"2023071114171614000_bnac034-B235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12020-009-9246-3","article-title":"Improvement of hypercortisolism by \u03b2-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia","volume":"36","author":"Oki","year":"2009","journal-title":"Endocrine"},{"issue":"5","key":"2023071114171614000_bnac034-B236","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3904\/kjim.2014.29.5.667","article-title":"Adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with abnormal cortisol secretion mediated by catecholamines","volume":"29","author":"Rhee","year":"2014","journal-title":"Korean J Intern Med"},{"issue":"21","key":"2023071114171614000_bnac034-B237","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","article-title":"Leuprolide acetate therapy in luteinizing hormone\u2013dependent Cushing's syndrome","volume":"341","author":"Lacroix","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"2023071114171614000_bnac034-B238","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1677\/ERC-08-0085","article-title":"Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol","volume":"15","author":"Louiset","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"2023071114171614000_bnac034-B239","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1210\/jc.2002-021949","article-title":"Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study","volume":"88","author":"Mannelli","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B240","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2002-021107","article-title":"Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"88","author":"Cartier","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B241","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/jc.2004-2476","article-title":"Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies","volume":"90","author":"Contesse","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023071114171614000_bnac034-B242","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-2004-825797","article-title":"Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors: in vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma","volume":"36","author":"Dall'Asta","year":"2004","journal-title":"Horm Metab Res"},{"issue":"11","key":"2023071114171614000_bnac034-B243","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1210\/jc.2019-00425","article-title":"Illicit upregulation of serotonin signaling pathway in adrenals of patients with high plasma or intra-adrenal ACTH levels","volume":"104","author":"Le Mestre","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B244","doi-asserted-by":"crossref","first-page":"K13","DOI":"10.1530\/EJE-17-0263","article-title":"Adrenal Cushing's syndrome during pregnancy","volume":"177","author":"Andreescu","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B245","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1210\/jc.2002-020621","article-title":"Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro","volume":"88","author":"Feelders","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023071114171614000_bnac034-B246","first-page":"456","article-title":"Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in vivo and in vitro observations","volume":"62","author":"Bovenberg","year":"2004","journal-title":"Neth J Med"},{"issue":"4","key":"2023071114171614000_bnac034-B247","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12022-009-9090-2","article-title":"Case report: adrenal LH\/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome","volume":"20","author":"Chui","year":"2009","journal-title":"Endocr Pathol"},{"issue":"1","key":"2023071114171614000_bnac034-B248","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2265.1991.tb01732.x","article-title":"Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency","volume":"34","author":"Leinonen","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023071114171614000_bnac034-B249","first-page":"2397","article-title":"Novel presence of luteinizing hormone\/chorionic gonadotropin receptors in human adrenal glands","volume":"81","author":"Pabon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B250","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jc.2003-030917","article-title":"Human fetal nongonadal tissues contain human chorionic gonadotropin\/luteinizing hormone receptors","volume":"89","author":"Abdallah","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B251","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1210\/jcem-46-5-834","article-title":"Role of hCG in regulation of the fetal zone of the human fetal adrenal gland","volume":"46","author":"Ser\u00f3n-Ferr\u00e9","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023071114171614000_bnac034-B252","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/en.2004-1643","article-title":"Gonadotropin-induced adrenocortical neoplasia in NU\/J nude mice","volume":"146","author":"Bielinska","year":"2005","journal-title":"Endocrinology"},{"issue":"2","key":"2023071114171614000_bnac034-B253","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1354\/vp.43-2-97","article-title":"Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse","volume":"43","author":"Bielinska","year":"2006","journal-title":"Vet Pathol"},{"issue":"12","key":"2023071114171614000_bnac034-B254","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0034-1384522","article-title":"Abnormal sensitivity to glucagon and related peptides in primary adrenal Cushing's Syndrome","volume":"46","author":"Louiset","year":"2014","journal-title":"Horm Metab Res"},{"issue":"3","key":"2023071114171614000_bnac034-B255","first-page":"254","article-title":"Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia","volume":"70","author":"de Miguel","year":"2010","journal-title":"Medicina (B Aires)"},{"issue":"10","key":"2023071114171614000_bnac034-B256","doi-asserted-by":"crossref","first-page":"E253","DOI":"10.1210\/jc.2009-2281","article-title":"Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome","volume":"95","author":"Assie","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B257","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00019616-199901000-00004","article-title":"Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome","volume":"9","author":"Lacroix","year":"1999","journal-title":"Endocrinologist"},{"key":"2023071114171614000_bnac034-B258","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coemr.2019.08.012","article-title":"Mechanism of ectopic hormone receptors in adrenal tumors and hyperplasia","volume":"8","author":"Kamenick\u00fd","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"7","key":"2023071114171614000_bnac034-B259","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1210\/jc.2002-030014","article-title":"Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"88","author":"Lefebvre","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","article-title":"The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH)","volume":"460","author":"Cavalcante","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2023071114171614000_bnac034-B261","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-13-0308","article-title":"Autocrine\/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism","volume":"169","author":"Lefebvre","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2023071114171614000_bnac034-B262","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000443864","article-title":"Metabolic alterations and cardiovascular outcomes of cortisol excess","volume":"46","author":"Pivonello","year":"2016","journal-title":"Front Horm Res"},{"issue":"1","key":"2023071114171614000_bnac034-B263","doi-asserted-by":"crossref","first-page":"e0191602","DOI":"10.1371\/journal.pone.0191602","article-title":"ARMC5 Mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia","volume":"13","author":"Yu","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"2023071114171614000_bnac034-B264","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"key":"2023071114171614000_bnac034-B266","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7326\/M21-4526","article-title":"Cardiometabolic morbidity of mild cortisol excess","volume":"175","author":"Lacroix","year":"2022","journal-title":"Ann Intern Med"},{"issue":"Suppl. 1","key":"2023071114171614000_bnac034-B267","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000314316","article-title":"Management of diabetes mellitus in Cushing's syndrome","volume":"92","author":"Munir","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2023071114171614000_bnac034-B268","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"2023071114171614000_bnac034-B269","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-13-0754","article-title":"Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?","volume":"170","author":"Giordano","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023071114171614000_bnac034-B270","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/er.2016-1105","article-title":"Glucose metabolism abnormalities in Cushing's syndrome: from molecular basis to clinical management","volume":"38","author":"Scaroni","year":"2017","journal-title":"Endocr Rev"},{"issue":"6","key":"2023071114171614000_bnac034-B271","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1507\/endocrj.43.645","article-title":"Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM","volume":"43","author":"Friedman","year":"1996","journal-title":"Endocr J"},{"issue":"1","key":"2023071114171614000_bnac034-B272","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1563-2571.2000.00106.x","article-title":"[Prevalence of diabetes in acromegaly and Cushing's syndrome]","volume":"27","author":"Biering","year":"2000","journal-title":"Acta Med Austriaca"},{"issue":"6","key":"2023071114171614000_bnac034-B273","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B274","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"5","key":"2023071114171614000_bnac034-B275","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-16-0967","article-title":"Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN","volume":"176","author":"Valassi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023071114171614000_bnac034-B276","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocr Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B277","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing's Syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol"},{"key":"2023071114171614000_bnac034-B278","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eprac.2022.04.011","article-title":"A 30-year single-center experience of unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia","volume":"28","author":"Wang","year":"2022","journal-title":"Endocr Pract"},{"issue":"3","key":"2023071114171614000_bnac034-B279","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023071114171614000_bnac034-B280","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B281","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B282","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"issue":"4","key":"2023071114171614000_bnac034-B283","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jocd.2019.09.001","article-title":"Least significant change and quality assurance in multiple dual-energy x-ray absorptiometry scanner environments: 2019 ISCD official position","volume":"22","author":"Jankowski","year":"2019","journal-title":"J Clin Densitom"},{"issue":"1","key":"2023071114171614000_bnac034-B284","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"2023071114171614000_bnac034-B285","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr Rev"},{"issue":"3","key":"2023071114171614000_bnac034-B286","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MED.0000000000000478","article-title":"Evaluation of bone health in patients with adrenal tumors","volume":"26","author":"Athimulam","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"2023071114171614000_bnac034-B287","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/EJE-12-0777","article-title":"Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics","volume":"168","author":"Morelli","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023071114171614000_bnac034-B288","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1210\/clinem\/dgaa120","article-title":"The impact of mild autonomous cortisol secretion on bone turnover markers","volume":"105","author":"Athimulam","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B289","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/17446651.2020.1772051","article-title":"Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis","volume":"15","author":"Chiodini","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B290","doi-asserted-by":"crossref","first-page":"782118","DOI":"10.3389\/fendo.2021.782118","article-title":"When to start and stop bone-protecting medication for preventing glucocorticoid-induced osteoporosis","volume":"12","author":"Hayes","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2023071114171614000_bnac034-B291","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0037-198X(88)80037-3","article-title":"Embryology, anatomy, and anomalies of the adrenal gland","volume":"23","author":"Mitty","year":"1988","journal-title":"Semin Roentgenol"},{"issue":"2","key":"2023071114171614000_bnac034-B292","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ecl.2005.01.004","article-title":"Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease","volume":"34","author":"Lacroix","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2023071114171614000_bnac034-B293","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archsurg.133.5.541","article-title":"Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation","volume":"133","author":"Swain","year":"1998","journal-title":"Arch Surg"},{"issue":"3","key":"2023071114171614000_bnac034-B294","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/EJE-20-1120","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: carney complex: clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene","volume":"184","author":"Bouys","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023071114171614000_bnac034-B295","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1507\/endocrj.41.429","article-title":"Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia: a case report and immunohistochemical studies","volume":"41","author":"Koizumi","year":"1994","journal-title":"Endocr J"},{"issue":"2","key":"2023071114171614000_bnac034-B296","first-page":"215","article-title":"ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes","volume":"7","author":"Sasano","year":"1994","journal-title":"Mod Pathol"},{"key":"2023071114171614000_bnac034-B297","doi-asserted-by":"crossref","first-page":"105316","DOI":"10.1016\/j.jsbmb.2019.02.011","article-title":"High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia","volume":"191","author":"Berthon","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2023071114171614000_bnac034-B298","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2002-021362","article-title":"Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene","volume":"88","author":"Fragoso","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023071114171614000_bnac034-B299","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.5858\/2008-132-1263-LOTAC","article-title":"Lesions of the adrenal cortex","volume":"132","author":"McNicol","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2023071114171614000_bnac034-B300","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1340583","article-title":"Adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia: immunohistochemical studies of steroidogenic enzymes and post-operative course in two men","volume":"134","author":"Wada","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023071114171614000_bnac034-B301","doi-asserted-by":"crossref","first-page":"E728","DOI":"10.1210\/jc.2010-2420","article-title":"Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions","volume":"96","author":"Almeida","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B302","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI115827","article-title":"Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells","volume":"90","author":"Spencer","year":"1992","journal-title":"J Clin Invest"},{"issue":"2","key":"2023071114171614000_bnac034-B303","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jcp.51.2.114","article-title":"Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin","volume":"51","author":"McCluggage","year":"1998","journal-title":"J Clin Pathol"},{"key":"2023071114171614000_bnac034-B304","article-title":"Inhibin A as a tumor marker for primary bilateral macronodular adrenal hyperplasia","author":"Wurth","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2023071114171614000_bnac034-B305","doi-asserted-by":"crossref","first-page":"111377","DOI":"10.1016\/j.mce.2021.111377","article-title":"Steroidogenic cell microenvironment and adrenal function in physiological and pathophysiological conditions","volume":"535","author":"Lopez","year":"2021","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"2023071114171614000_bnac034-B306","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S2213-8587(21)00178-9","article-title":"Adrenal myelolipomas","volume":"9","author":"Calissendorff","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"45","key":"2023071114171614000_bnac034-B307","doi-asserted-by":"crossref","first-page":"13922","DOI":"10.1073\/pnas.1517326112","article-title":"LSD1\/KDM1A Promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2","volume":"112","author":"Takeuchi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023071114171614000_bnac034-B308","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cen.14188","article-title":"Clinical course of adrenal myelolipoma: a long-term longitudinal follow-up study","volume":"93","author":"Hamidi","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023071114171614000_bnac034-B309","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12020-017-1410-6","article-title":"The radiographically diagnosed adrenal myelolipoma: what do we really know?","volume":"58","author":"Campbell","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"2023071114171614000_bnac034-B310","first-page":"45","article-title":"Adrenal myelolipomas composed with adrenal nodular hyperplasia in the same gland","volume":"63","author":"Babinska","year":"2012","journal-title":"Pol J Pathol"},{"issue":"9-10","key":"2023071114171614000_bnac034-B311","doi-asserted-by":"crossref","first-page":"E637","DOI":"10.5489\/cuaj.422","article-title":"Pathologic analysis, diagnosis and treatment of adrenal myelolipoma","volume":"8","author":"Su","year":"2014","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"2023071114171614000_bnac034-B312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2012.04403.x","article-title":"Genetic aspects of adrenocortical tumours and hyperplasias","volume":"77","author":"Mazzuco","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5311","key":"2023071114171614000_bnac034-B313","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"6","key":"2023071114171614000_bnac034-B314","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"2023071114171614000_bnac034-B315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-5347(05)66068-5","article-title":"Multiple endocrine neoplasia type 1 and adrenal lesions","volume":"166","author":"Barzon","year":"2001","journal-title":"J Urol"},{"issue":"4","key":"2023071114171614000_bnac034-B316","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening","volume":"392","author":"Waldmann","year":"2007","journal-title":"Langenbecks Arch Surg"},{"issue":"7","key":"2023071114171614000_bnac034-B317","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/archsurg.1996.01430190021006","article-title":"Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1","volume":"131","author":"Burgess","year":"1996","journal-title":"Arch Surg"},{"issue":"1","key":"2023071114171614000_bnac034-B318","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12902-022-01022-6","article-title":"Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review","volume":"22","author":"Chavoshi","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2023071114171614000_bnac034-B319","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.4158\/EP10213.CR","article-title":"Corticotropin-independent macronodular adrenal hyperplasia associated with insulinoma","volume":"17","author":"Lee","year":"2011","journal-title":"Endocr Pract"},{"issue":"1","key":"2023071114171614000_bnac034-B320","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.53.111","article-title":"A case of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) with primary hyperparathyroidism (PHPT)","volume":"53","author":"Sato","year":"2006","journal-title":"Endocr J"},{"issue":"4","key":"2023071114171614000_bnac034-B321","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.K10E-218","article-title":"A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1","volume":"58","author":"Yoshida","year":"2011","journal-title":"Endocr J"},{"issue":"12","key":"2023071114171614000_bnac034-B322","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/BF02236860","article-title":"Adrenal masses are associated with familial adenomatous polyposis","volume":"43","author":"Smith","year":"2000","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"2023071114171614000_bnac034-B323","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/BF02050923","article-title":"Adrenal masses in patients with familial adenomatous polyposis","volume":"40","author":"Marchesa","year":"1997","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"2023071114171614000_bnac034-B324","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0092-8674(00)00122-7","article-title":"Linking colorectal cancer to Wnt signaling","volume":"103","author":"Bienz","year":"2000","journal-title":"Cell"},{"issue":"21","key":"2023071114171614000_bnac034-B325","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2023071114171614000_bnac034-B326","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2016-1874","article-title":"Aldosterone-Producing adenoma with a somatic KCNJ5 mutation revealing APC-dependent familial adenomatous polyposis","volume":"101","author":"Vouillarmet","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B327","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/ERC-21-0298","article-title":"\u03b2-Catenin activation and illicit receptor expression in adrenocortical cells","volume":"29","author":"Le Mestre","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2023071114171614000_bnac034-B328","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"2023071114171614000_bnac034-B329","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2023071114171614000_bnac034-B330","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/EJE-15-0205","article-title":"The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B331","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13256-017-1529-3","article-title":"Extensive ARMC5 genetic variance in primary bilateral macronodular adrenal hyperplasia that started with exophthalmos: a case report","volume":"12","author":"Jin","year":"2018","journal-title":"J Med Case Rep"},{"key":"2023071114171614000_bnac034-B332","first-page":"16-0135","article-title":"ARMC5 mutation in a Portuguese family with primary bilateral macronodular adrenal hyperplasia (PBMAH)","volume":"2017","author":"Rego","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"2023071114171614000_bnac034-B333","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.EJ17-0317","article-title":"Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia","volume":"65","author":"Zhang","year":"2018","journal-title":"Endocr J"},{"issue":"3","key":"2023071114171614000_bnac034-B334","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12020-016-0988-4","article-title":"Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?","volume":"53","author":"Emms","year":"2016","journal-title":"Endocrine"},{"issue":"8","key":"2023071114171614000_bnac034-B335","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1210\/clinem\/dgaa290","article-title":"The association of ARMC5 with the renin-angiotensin-aldosterone system, blood pressure, and glycemia in African Americans","volume":"105","author":"Joseph","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B336","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/jhh.2015.98","article-title":"ARMC5 Mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions","volume":"30","author":"Mulatero","year":"2016","journal-title":"J Hum Hypertens"},{"issue":"12","key":"2023071114171614000_bnac034-B337","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/jhh.2017.71","article-title":"ARMC5 Is not implicated in familial hyperaldosteronism type II (FH-II)","volume":"31","author":"De Sousa","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2023071114171614000_bnac034-B338","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B339","first-page":"8848151","article-title":"ARMC5 Primary bilateral macronodular adrenal hyperplasia associated with a meningioma: A family report","volume":"2020","author":"Ferreira","year":"2020","journal-title":"Case Rep Endocrinol"},{"issue":"6","key":"2023071114171614000_bnac034-B340","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-20-0014","article-title":"Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report","volume":"183","author":"Jojima","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2023071114171614000_bnac034-B341","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2016.08.018","article-title":"Analysis of ARMC5 expression in human tissues","volume":"441","author":"Berthon","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2023071114171614000_bnac034-B342","first-page":"516","article-title":"Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1","volume":"63","author":"Ventura","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"12","key":"2023071114171614000_bnac034-B343","doi-asserted-by":"crossref","first-page":"e4531","DOI":"10.1210\/clinem\/dgaa631","article-title":"ARMC5 Alterations in patients with sporadic neuroendocrine tumors and multiple endocrine neoplasia type 1 (MEN1)","volume":"105","author":"Damjanovic","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071114171614000_bnac034-B344","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/ERC-20-0128","article-title":"Genomic classification of benign adrenocortical lesions","volume":"28","author":"Faillot","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"2023071114171614000_bnac034-B345","doi-asserted-by":"crossref","first-page":"105414","DOI":"10.1016\/j.jsbmb.2019.105414","article-title":"Genomics of benign adrenocortical tumors","volume":"193","author":"Jouinot","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"2023071114171614000_bnac034-B346","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa075","article-title":"Molecular basis of primary aldosteronism and adrenal Cushing's syndrome","volume":"4","author":"Vaduva","year":"2020","journal-title":"J Endocr Soc"},{"issue":"4","key":"2023071114171614000_bnac034-B347","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-19-0502","article-title":"Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation","volume":"27","author":"Cavalcante","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"2023071114171614000_bnac034-B348","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1093\/nar\/gkac483","article-title":"ARMC5 Is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia","volume":"50","author":"Lao","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2023071114171614000_bnac034-B349","doi-asserted-by":"crossref","first-page":"e151390","DOI":"10.1172\/jci.insight.151390","article-title":"ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumor","volume":"7","author":"Okuno","year":"2022","journal-title":"JCI Insight"},{"issue":"11","key":"2023071114171614000_bnac034-B350","first-page":"615","article-title":"Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover","volume":"29","author":"Cavalcante","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"18","key":"2023071114171614000_bnac034-B351","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","article-title":"Age-dependent effects of ARMC5 haploinsufficiency on adrenocortical function","volume":"26","author":"Berthon","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2023071114171614000_bnac034-B352","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1038\/ncomms13834","article-title":"Armc5 deletion causes developmental defects and compromises T-cell immune responses","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"issue":"7","key":"2023071114171614000_bnac034-B353","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"issue":"2","key":"2023071114171614000_bnac034-B354","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc3884","article-title":"Critical roles of non-histone protein lysine methylation in human tumorigenesis","volume":"15","author":"Hamamoto","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2023071114171614000_bnac034-B355","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/s41467-020-16017-x","article-title":"LSD1-mediated Enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development","volume":"11","author":"Vinckier","year":"2020","journal-title":"Nat Commun"},{"issue":"7138","key":"2023071114171614000_bnac034-B356","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature05671","article-title":"Opposing LSD1 complexes function in developmental gene activation and repression programmes","volume":"446","author":"Wang","year":"2007","journal-title":"Nature"},{"issue":"10","key":"2023071114171614000_bnac034-B357","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/0008-5472.CAN-17-1900","article-title":"Germline lysine-specific demethylase 1 (LSD1\/KDM1A) mutations confer susceptibility to multiple myeloma","volume":"78","author":"Wei","year":"2018","journal-title":"Cancer Res"},{"issue":"2","key":"2023071114171614000_bnac034-B358","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2003.10.052","article-title":"Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missense mutations in the MC2R gene","volume":"213","author":"Swords","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2023071114171614000_bnac034-B359","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2009-2321","article-title":"Cushing's syndrome in the McCune-Albright syndrome","volume":"95","author":"Brown","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B360","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fendo.2016.00104","article-title":"The role of gsp mutations on the development of adrenocortical tumors and adrenal hyperplasia","volume":"7","author":"Villares Fragoso","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2023071114171614000_bnac034-B361","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Lib\u00e9","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2023071114171614000_bnac034-B362","doi-asserted-by":"crossref","first-page":"E2063","DOI":"10.1210\/jc.2012-2275","article-title":"Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors","volume":"97","author":"Vezzosi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2023071114171614000_bnac034-B363","doi-asserted-by":"crossref","first-page":"111071","DOI":"10.1016\/j.mce.2020.111071","article-title":"A phosphodiesterase 11 (Pde11a) knockout mouse expressed functional but reduced Pde11a: phenotype and impact on adrenocortical function","volume":"520","author":"Levy","year":"2021","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2023071114171614000_bnac034-B364","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","article-title":"Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours","volume":"77","author":"Rothenbuhler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2023071114171614000_bnac034-B365","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"2023071114171614000_bnac034-B366","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's Syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2023071114171614000_bnac034-B367","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023071114171614000_bnac034-B368","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12920-021-00896-0","article-title":"A novel nonsense mutation in ARMC5 causes primary bilateral macronodular adrenocortical hyperplasia","volume":"14","author":"He","year":"2021","journal-title":"BMC Med Genomics"},{"issue":"3","key":"2023071114171614000_bnac034-B369","doi-asserted-by":"crossref","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","article-title":"Adrenocortical hyperplasia: a multifaceted disease","volume":"34","author":"Bourdeau","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B370","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"8","key":"2023071114171614000_bnac034-B371","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's Syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071114171614000_bnac034-B372","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2023071114171614000_bnac034-B373","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071114171614000_bnac034-B374","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","article-title":"Advances in the medical treatment of Cushing's syndrome","volume":"7","author":"Feelders","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023071114171614000_bnac034-B375","first-page":"140083","article-title":"Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia","volume":"2014","author":"Comte-Perret","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"11","key":"2023071114171614000_bnac034-B376","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071114171614000_bnac034-B377","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1507\/endocrj.48.665","article-title":"Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH)","volume":"48","author":"Omori","year":"2001","journal-title":"Endocr J"},{"issue":"1","key":"2023071114171614000_bnac034-B378","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12020-011-9549-z","article-title":"Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia","volume":"41","author":"Yoshida","year":"2012","journal-title":"Endocrine"},{"key":"2023071114171614000_bnac034-B379","article-title":"Synergistic cortisol suppression by ketoconazole-osilodrostat combination therapy","author":"Amodru","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"9","key":"2023071114171614000_bnac034-B380","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023071114171614000_bnac034-B381","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1210\/jc.2018-02638","article-title":"Mifepristone treatment in four cases of primary bilateral macronodular adrenal hyperplasia (BMAH)","volume":"104","author":"Cohan","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071114171614000_bnac034-B382","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00125-017-4447-4","article-title":"GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study","volume":"61","author":"Gasbjerg","year":"2018","journal-title":"Diabetologia"},{"issue":"21","key":"2023071114171614000_bnac034-B383","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.2169\/internalmedicine.50.5578","article-title":"Long-term efficacy of trilostane for Cushing's syndrome due to adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia","volume":"50","author":"Obata","year":"2011","journal-title":"Intern Med"},{"issue":"12","key":"2023071114171614000_bnac034-B384","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2169\/internalmedicine.38.969","article-title":"Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia treated with mitotane","volume":"38","author":"Nagai","year":"1999","journal-title":"Intern Med"},{"issue":"1","key":"2023071114171614000_bnac034-B385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2023071114171614000_bnac034-B386","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2023071114171614000_bnac034-B387","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1507\/endocrj.K08E-370","article-title":"Adrenal Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: prediction of the efficacy of beta-blockade therapy and interest of unilateral adrenalectomy","volume":"56","author":"Mazzuco","year":"2009","journal-title":"Endocr J"},{"issue":"849","key":"2023071114171614000_bnac034-B388","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/pgmj.72.849.403","article-title":"Somatostatin analogue treatment of neuroendocrine tumours","volume":"72","author":"de Herder","year":"1996","journal-title":"Postgrad Med J"},{"key":"2023071114171614000_bnac034-B389","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.peptides.2017.11.021","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents","volume":"100","author":"Gasbjerg","year":"2018","journal-title":"Peptides"},{"issue":"1","key":"2023071114171614000_bnac034-B390","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071114171614000_bnac034-B391","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review: outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023071114171614000_bnac034-B392","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/SLE.0b013e318290126d","article-title":"Laparoscopic bilateral transperitoneal adrenalectomy for Cushing's syndrome: surgical challenges and lessons learnt","volume":"23","author":"Aggarwal","year":"2013","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"issue":"2","key":"2023071114171614000_bnac034-B393","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-15-0541","article-title":"Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?","volume":"23","author":"Guerin","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2023071114171614000_bnac034-B394","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00464-002-9243-6","article-title":"Synchronous bilateral endoscopic adrenalectomy: experiences after 18 operations","volume":"18","author":"J\u00e4ger","year":"2004","journal-title":"Surg Endosc"},{"issue":"6","key":"2023071114171614000_bnac034-B395","first-page":"1138","article-title":"Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy","volume":"114","author":"Zeiger","year":"1993","journal-title":"Surgery"},{"issue":"852","key":"2023071114171614000_bnac034-B396","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/pgmj.72.852.614","article-title":"Cushing's syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy","volume":"72","author":"Boronat","year":"1996","journal-title":"Postgrad Med J"},{"issue":"2","key":"2023071114171614000_bnac034-B397","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1530\/eje.0.1460237","article-title":"Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases","volume":"146","author":"Lamas","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023071114171614000_bnac034-B398","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1507\/endocrj.50.715","article-title":"Unilateral adrenalectomy improves insulin resistance and diabetes mellitus in a patient with ACTH-independent macronodular adrenal hyperplasia","volume":"50","author":"Ogura","year":"2003","journal-title":"Endocr J"},{"issue":"5","key":"2023071114171614000_bnac034-B399","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00268-007-9408-5","article-title":"The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH)","volume":"32","author":"Iacobone","year":"2008","journal-title":"World J Surg"},{"issue":"9","key":"2023071114171614000_bnac034-B400","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1507\/endocrj.K10E-003","article-title":"Unilateral adrenalectomy can be an alternative therapy for infantile onset Cushing's\u2019 s syndrome caused by ACTH-independent macronodular adrenal hyperplasia with McCune-Albright syndrome","volume":"57","author":"Hamajima","year":"2010","journal-title":"Endocr J"},{"issue":"13","key":"2023071114171614000_bnac034-B401","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2169\/internalmedicine.51.7041","article-title":"Usefulness and limitations of unilateral adrenalectomy for ACTH-independent macronodular adrenal hyperplasia in a patient with poor glycemic control","volume":"51","author":"Kobayashi","year":"2012","journal-title":"Intern Med"},{"issue":"3","key":"2023071114171614000_bnac034-B402","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000347130","article-title":"Laparoscopic enucleation of macronodules in a patient with ACTH-independent macronodular adrenal hyperplasia 7 years after unilateral adrenalectomy: consideration of operative procedure","volume":"90","author":"Ito","year":"2013","journal-title":"Urol Int"},{"issue":"3","key":"2023071114171614000_bnac034-B403","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4158\/EP12277.RA","article-title":"Challenges in the diagnostic work-up and management of patients with subclinical Cushing's syndrome and bilateral adrenal masses","volume":"19","author":"Maghrabi","year":"2013","journal-title":"Endocr Pract"},{"issue":"7","key":"2023071114171614000_bnac034-B404","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00268-013-2059-9","article-title":"The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias","volume":"37","author":"Xu","year":"2013","journal-title":"World J Surg"},{"issue":"2","key":"2023071114171614000_bnac034-B405","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3892\/etm.2014.2115","article-title":"Diagnosis and treatment of adrenocorticotrophic hormone-independent macronodular adrenocortical hyperplasia: a report of 23 cases in a single center","volume":"9","author":"Li","year":"2015","journal-title":"Exp Ther Med"},{"issue":"12","key":"2023071114171614000_bnac034-B406","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1055\/a-0998-7884","article-title":"Unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia: analysis of 71 cases","volume":"128","author":"Sheikh-Ahmad","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2023071114171614000_bnac034-B407","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/TCRM.S196171","article-title":"Retention of aberrant cortisol secretion in a patient with bilateral macronodular adrenal hyperplasia after unilateral adrenalectomy","volume":"15","author":"Tanaka","year":"2019","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"2023071114171614000_bnac034-B408","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13340-021-00503-8","article-title":"Unilateral adrenalectomy partially improved hyperglycemia in a patient with primary bilateral macronodular adrenal hyperplasia","volume":"12","author":"Nishiyama","year":"2021","journal-title":"Diabetol Int"},{"issue":"10","key":"2023071114171614000_bnac034-B409","first-page":"19311","article-title":"Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2023071114171614000_bnac034-B410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12881-018-0564-2","article-title":"A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report","volume":"19","author":"Liu","year":"2018","journal-title":"BMC Med Genet"},{"issue":"1","key":"2023071114171614000_bnac034-B411","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1752-1947-6-312","article-title":"Successful treatment for adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with laparoscopic adrenalectomy: a case series","volume":"6","author":"Ito","year":"2012","journal-title":"J Med Case Rep"},{"key":"2023071114171614000_bnac034-B412","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.coemr.2019.08.001","article-title":"Unilateral adrenalectomy in primary bilateral macronodular hyperplasia","volume":"8","author":"Cristante","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"6","key":"2023071114171614000_bnac034-B413","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","article-title":"Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study","volume":"15","author":"Castinetti","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"2023071114171614000_bnac034-B414","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1634\/theoncologist.2012-0410","article-title":"Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas","volume":"18","author":"Lowery","year":"2013","journal-title":"Oncologist"},{"issue":"5","key":"2023071114171614000_bnac034-B415","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00268-008-9513-0","article-title":"Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia","volume":"32","author":"Walz","year":"2008","journal-title":"World J Surg"},{"issue":"5","key":"2023071114171614000_bnac034-B416","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00268-007-9332-8","article-title":"The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses","volume":"32","author":"Young","year":"2008","journal-title":"World J Surg"},{"issue":"11","key":"2023071114171614000_bnac034-B417","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1442-2042.2011.02846.x","article-title":"Laparoscopic simultaneous bilateral adrenalectomy: assessment of feasibility and potential indications","volume":"18","author":"Kawasaki","year":"2011","journal-title":"Int J Urol"},{"issue":"5","key":"2023071114171614000_bnac034-B418","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00423-017-1569-6","article-title":"Posterior retroperitoneoscopic adrenal surgery for clinical and subclinical Cushing's syndrome in patients with bilateral adrenal disease","volume":"402","author":"Lowery","year":"2017","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"2023071114171614000_bnac034-B419","doi-asserted-by":"crossref","first-page":"bvaa083","DOI":"10.1210\/jendso\/bvaa083","article-title":"A new insight into the surgical treatment of primary macronodular adrenal hyperplasia","volume":"4","author":"Yoshiaki Tanno","year":"2020","journal-title":"J Endocr Soc"},{"issue":"10","key":"2023071114171614000_bnac034-B420","doi-asserted-by":"crossref","first-page":"600","DOI":"10.6061\/clinics\/2016(10)08","article-title":"Long-term results after CT-guided percutaneous ethanol ablation for the treatment of hyperfunctioning adrenal disorders","volume":"71","author":"Frenk","year":"2016","journal-title":"Clinics (Sao Paulo)"},{"issue":"10","key":"2023071114171614000_bnac034-B421","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1530\/EC-20-0419","article-title":"Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas","volume":"9","author":"Ueland","year":"2020","journal-title":"Endocr Connect"},{"issue":"2","key":"2023071114171614000_bnac034-B422","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00268-018-4788-2","article-title":"Outcomes of adrenal venous sampling in patients with bilateral adrenal masses and ACTH-independent Cushing's syndrome","volume":"43","author":"Acharya","year":"2019","journal-title":"World J Surg"},{"issue":"2","key":"2023071114171614000_bnac034-B423","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12020-022-03020-z","article-title":"The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients","volume":"76","author":"Rubinstein","year":"2022","journal-title":"Endocrine"},{"key":"2023071114171614000_bnac034-B424","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.urology.2015.11.043","article-title":"The use of three-dimensional printers for partial adrenalectomy: estimating the resection limits","volume":"90","author":"Srougi","year":"2016","journal-title":"Urology"},{"issue":"2","key":"2023071114171614000_bnac034-B425","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1620\/tjem.253.143","article-title":"The potential of computed tomography volumetry for the surgical treatment in bilateral macronodular adrenal hyperplasia: a case report","volume":"253","author":"Matsunaga","year":"2021","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"2023071114171614000_bnac034-B426","doi-asserted-by":"crossref","first-page":"101496","DOI":"10.1016\/j.beem.2021.101496","article-title":"Hypercoagulability in Cushing's syndrome: from arterial to venous disease","volume":"35","author":"St-Jean","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"2023071114171614000_bnac034-B427","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnac034\/49228769\/bnac034.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/4\/567\/50854322\/bnac034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/4\/567\/50854322\/bnac034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T18:29:04Z","timestamp":1728584944000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/44\/4\/567\/6957368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":427,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12,22]]},"published-print":{"date-parts":[[2023,7,11]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnac034","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2022,12,22]]}}}